Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad373.
The association between volume, complications and pathological outcomes is still under debate regarding colorectal cancer surgery. The aim of the study was to assess the association between centre volume and severe complications, mortality, less-than-radical oncologic surgery, and indications for neoadjuvant therapy.
Retrospective analysis of 16,883 colorectal cancer cases from 80 centres (2018-2021). Outcomes: 30-day mortality; Clavien-Dindo grade >2 complications; removal of ≥ 12 lymph nodes; non-radical resection; neoadjuvant therapy. Quartiles of hospital volumes were classified as LOW, MEDIUM, HIGH, and VERY HIGH. Independent predictors, both overall and for rectal cancer, were evaluated using logistic regression including age, gender, AJCC stage and cancer site.
LOW-volume centres reported a higher rate of severe postoperative complications (OR 1.50, 95% c.i. 1.15-1.096, P = 0.003). The rate of ≥ 12 lymph nodes removed in LOW-volume (OR 0.68, 95% c.i. 0.56-0.85, P < 0.001) and MEDIUM-volume (OR 0.72, 95% c.i. 0.62-0.83, P < 0.001) centres was lower than in VERY HIGH-volume centres. Of the 4676 rectal cancer patients, the rate of ≥ 12 lymph nodes removed was lower in LOW-volume than in VERY HIGH-volume centres (OR 0.57, 95% c.i. 0.41-0.80, P = 0.001). A lower rate of neoadjuvant chemoradiation was associated with HIGH (OR 0.66, 95% c.i. 0.56-0.77, P < 0.001), MEDIUM (OR 0.75, 95% c.i. 0.60-0.92, P = 0.006), and LOW (OR 0.70, 95% c.i. 0.52-0.94, P = 0.019) volume centres (vs. VERY HIGH).
Colorectal cancer surgery in low-volume centres is at higher risk of suboptimal management, poor postoperative outcomes, and less-than-adequate oncologic resections. Centralisation of rectal cancer cases should be taken into consideration to optimise the outcomes.
关于结直肠癌手术,肿瘤量、并发症和病理结果之间的关系仍存在争议。本研究旨在评估中心肿瘤量与严重并发症、死亡率、非根治性肿瘤手术以及新辅助治疗指征之间的关系。
对 80 个中心的 16883 例结直肠癌病例进行回顾性分析(2018-2021 年)。结局指标:30 天死亡率;Clavien-Dindo 分级>2 级并发症;切除≥12 枚淋巴结;非根治性切除;新辅助治疗。将医院容量的四分位数分为低、中、高和极高。使用逻辑回归(包括年龄、性别、AJCC 分期和癌症部位)评估总体和直肠癌的独立预测因素。
低容量中心报告严重术后并发症的发生率较高(OR 1.50,95%置信区间 1.15-1.096,P=0.003)。低容量(OR 0.68,95%置信区间 0.56-0.85,P<0.001)和中容量(OR 0.72,95%置信区间 0.62-0.83,P<0.001)中心切除≥12 枚淋巴结的比例低于极高容量中心。在 4676 例直肠肿瘤患者中,低容量中心切除≥12 枚淋巴结的比例低于极高容量中心(OR 0.57,95%置信区间 0.41-0.80,P=0.001)。与高(OR 0.66,95%置信区间 0.56-0.77,P<0.001)、中(OR 0.75,95%置信区间 0.60-0.92,P=0.006)和低(OR 0.70,95%置信区间 0.52-0.94,P=0.019)容量中心相比,新辅助放化疗的比例较低(vs. 极高容量)。
低容量中心的结直肠癌手术存在治疗效果不佳、术后结局不良和肿瘤切除不足的风险更高。应考虑集中直肠肿瘤病例,以优化结局。